Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo
Open Access
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 27 (5) , 1017-1027
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (16cm0106202h001)
- SHIONOGI, japan
This publication has 47 references indexed in Scilit:
- Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNAJournal of Controlled Release, 2016
- PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumorsOncotarget, 2016
- Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cellsBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2014
- Delivery materials for siRNA therapeuticsNature Materials, 2013
- Chemically Modified Synthetic microRNA-205 Inhibits the Growth of Melanoma Cells In Vitro and In VivoMolecular Therapy, 2013
- Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinomaExpert Review of Anticancer Therapy, 2010
- siRNA-Based Therapy Ameliorates GlomerulonephritisJournal of the American Society of Nephrology, 2010
- MicroRNA-143 as a Tumor Suppressor for Bladder CancerJournal of Urology, 2009
- K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human FibroblastsCancer Research, 2005
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000